-
23/11/2022 Japanese company REPROCELL invests in HistocellREPROCELL Inc. decided to invest in Histocell S.L. to strengthen its clinical induced pluripotent stem...
-
17/11/2022 Histocell inaugurates new manufacturing plant for advanced therapy medicinal productsHistocell has inaugurated this morning its manufacturing plant in Larrabetzu, dedicated to cell therapy and...
-
31/05/2021 Cardiva expands its business by acquiring a stake in the biopharmaceutical company HistocellThe company has decided to join one of the most renowned Spanish companies in the...
-
08/02/2021 Histocell and Cardiva join forces to introduce the innovative wound care product Reoxcare throughout the Spanish healthcare system.The Basque biopharmaceutical company Histocell and the company Cardiva join forces to introduce the innovative...
-
10/01/2021 Technological cosmeticsTEKNOPOLIS - EITB The Basque company Histocell researches the world of dermocosmetics, bringing together medicine...
-
17/12/2020 Histocell successfully completes the clinical safety phase of its cell therapy drug HC016 for the treatment of acute respiratory distress caused by covid-19Histocell has successfully completed phase I of the clinical trial of the cell therapy drug...
-
01/09/2020 Histocell joins forces with seven companies in the Bio-Health area to launch the IMABI projectEight Basque companies, as well as various agents of the Basque Science, Technology and Innovation...
